This invention provides compounds of formula (I):
wherein R
1
, R
2
, X, p, q, m, n, and Ring C have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.
该发明提供了化合物的结构式(I):
其中R1、R2、X、p、q、m、n和环C的取值如规范中所述,可用作H
DAC6的
抑制剂。该发明还提供了包含该发明化合物的药物组合物以及使用该组合物治疗增生性、炎症性、感染性、神经系统或心血管疾病或障碍的方法。